ProQR Therapeutics (PRQR) Retained Earnings (2021 - 2024)
Historic Retained Earnings for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to -$456.5 million.
- ProQR Therapeutics' Retained Earnings fell 583.56% to -$456.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$456.5 million, marking a year-over-year decrease of 583.56%. This contributed to the annual value of -$462.3 million for FY2024, which is 662.42% down from last year.
- Latest data reveals that ProQR Therapeutics reported Retained Earnings of -$456.5 million as of Q4 2024, which was down 583.56% from -$431.3 million recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Retained Earnings registered a high of -$363.5 million during Q4 2021, and its lowest value of -$456.5 million during Q4 2024.
- Its 4-year average for Retained Earnings is -$409.5 million, with a median of -$409.0 million in 2023.
- In the last 5 years, ProQR Therapeutics' Retained Earnings tumbled by 1150.65% in 2023 and then plummeted by 583.56% in 2024.
- Quarter analysis of 4 years shows ProQR Therapeutics' Retained Earnings stood at -$363.5 million in 2021, then decreased by 6.4% to -$386.8 million in 2022, then decreased by 11.51% to -$431.3 million in 2023, then fell by 5.84% to -$456.5 million in 2024.
- Its last three reported values are -$456.5 million in Q4 2024, -$431.3 million for Q4 2023, and -$386.8 million during Q4 2022.